DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Tolaney SM, Guo H, Pernas S. et al.
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer.
J Clin Oncol 2019;
37: 1868-1875
doi:10.1200/JCO.19.00066
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.